CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- PositionGross margin is 17.2%, lower than 95% of its Diagnostics & Research peers (median 56.7%)
- FinancialsAltman Z-Score 10.12: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.56BCNY830.99M · vs all stocks (USD)
Revenue (TTM)
648.86MCNY96.89M · vs all stocks (USD)
Profit Margin
-5.21%vs Diagnostics & Research peers
Beta
-0.1520xvs all stocks
52-Week Change
97.29%vs all stocks
Market Capitalization
5.56BCNY830.99M · vs all stocks (USD)
Enterprise Value
5.33BCNY795.21M · vs all stocks (USD)
Price to Sales (TTM)
8.37xvs Diagnostics & Research peers
Price to Book (MRQ)
5.23xvs Diagnostics & Research peers
Enterprise to Revenue
8.21xvs Diagnostics & Research peers
Enterprise to EBITDA
-158.18xvs Diagnostics & Research peers
Gross Margin
17.21%vs Diagnostics & Research peers
Profit Margin
-5.21%vs Diagnostics & Research peers
Operating Margin
0.40%vs Diagnostics & Research peers
Return on Assets (TTM)
-1.65%vs Diagnostics & Research peers
Return on Equity (TTM)
-3.13%vs Diagnostics & Research peers
Revenue (TTM)
648.86MCNY96.89M · vs all stocks (USD)
Revenue per Share (TTM)
1.53CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-3.90%vs Diagnostics & Research peers
Gross Profit (TTM)
95.47MCNY14.26M · vs all stocks (USD)
EBITDA (TTM)
-33.66MCNY-5.03M · vs all stocks (USD)
Net Income (TTM)
-33.80MCNY-5.05M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.93%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
-54.82MCNY-8.19M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-33.42MCNY-4.99M · vs all stocks (USD)
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
1.74MCNYFY2025 · Dec 31, 2025Revenue
677.79MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
577.78MCNYFY2025 · Dec 31, 2025Gross Profit
100.01MCNYFY2025 · Dec 31, 2025Operating Income
-23.53MCNY-3.51M · vs all stocks (USD)
Pre-tax Income
-40.12MCNYFY2025 · Dec 31, 2025Income Tax Expense
-6.43MCNYFY2025 · Dec 31, 2025Net Income
-33.69MCNYFY2025 · Dec 31, 2025EBIT
-37.80MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-10.15MCNYFY2025 · Dec 31, 2025Research & Development
3.81MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
39.87MCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.32MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
-33.69MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
44.76KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-29.60MCNYFY2025 · Dec 31, 2025Free Cash Flow
-43.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
86.40MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-33.69MCNYFY2025 · Dec 31, 2025Other Non-cash Items
17.29MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
4.20MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-17.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-14.04MCNYFY2025 · Dec 31, 2025Purchase of Investments
-286.63MCNYFY2025 · Dec 31, 2025Sale of Investments
158.26MCNYFY2025 · Dec 31, 2025Other Investing Activity
1.26MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-141.16MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
126.97MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-114.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-52.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
6.39MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-34.28MCNYFY2025 · Dec 31, 2025Shares Outstanding
398.05MSharesUpdated Sep 22, 2026Float Shares
172.39MSharesUpdated Sep 22, 2026% Held by Insiders
54.20%vs all stocks
% Held by Institutions
1.78%vs all stocks
Total Cash (MRQ)
137.90MCNY20.59M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3460CNYUpdated Sep 22, 2026Total Debt (MRQ)
31.41MCNY4.69M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0302xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.96xvs Diagnostics & Research peers
Book Value per Share (MRQ)
2.61CNYUpdated Sep 22, 2026Total Assets
1.43BCNY213.32M · vs all stocks (USD)
Total Current Assets
1.12BCNYFY2025 · Dec 31, 2025Total Liabilities
368.90MCNYFY2025 · Dec 31, 2025Total Non-current Assets
304.24MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.02MCNYFY2025 · Dec 31, 2025Total Current Liabilities
366.88MCNYFY2025 · Dec 31, 2025Cash
96.40MCNYFY2025 · Dec 31, 2025Cash Equivalents
10.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
106.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
690.03MCNYFY2025 · Dec 31, 2025Inventory
172.64MCNYFY2025 · Dec 31, 2025Accounts Payable
266.40MCNYFY2025 · Dec 31, 2025Short-term Debt
59.26MCNYFY2025 · Dec 31, 2025Other Current Liabilities
361.94KCNYFY2025 · Dec 31, 2025Long-term Debt
2.02MCNYFY2025 · Dec 31, 2025Common Stock (Book)
398.05MCNYFY2025 · Dec 31, 2025Retained Earnings
43.93MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BCNY158.23M · vs all stocks (USD)
52-Week Low
6.12CNYUpdated Sep 22, 202652-Week High
31.22CNYUpdated Sep 22, 202652-Week Change
97.29%vs all stocks
Beta
-0.1520xvs all stocks
50-Day MA
11.75CNYUpdated Sep 22, 2026200-Day MA
15.63CNYUpdated Sep 22, 2026Avg 10-Day Volume
39.76MSharesUpdated Sep 22, 2026Avg 30-Day Volume
30.23MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.0800CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 17.2%, lower than 95% of its Diagnostics & Research peers (median 56.7%)Significant
Gross margin: 0.17Industry median: 0.57Industry P5: 0.22Peers compared: 30.00
Financial Health
Altman Z-Score 10.12: safe zoneNotable
Altman Z-Score: 10.12
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Dalian Insulator Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Çimsa Çimento Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Yonggui Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Newonder Special Electric Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Asrock Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Halo Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Weihaishi Honglin Electronics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
BMC Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
GNG Electronics Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Yaohua Pilkington Glass Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hanshang Group Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Hangzhou Electronic Soul Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Guangzhou LBP Medicine Science & Technology Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease